Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease.
Paulina KrawiecElżbieta Pac-KożuchowskaPublished in: Journal of inflammation research (2021)
Serum cathelicidin is increased in children with Crohn's disease and ulcerative colitis regardless of clinical activity of the disease suggesting that it may be a potential biomarker of IBD. Inverse correlation between cathelicidin and fecal calprotectin may imply a disparate role of these molecules in the pathophysiology of pediatric ulcerative colitis.